Strong evidence for genotype-phenotype correlations in Phelan-McDermid syndrome: results from the developmental synaptopathies consortium.
Journal
Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958
Informations de publication
Date de publication:
21 02 2022
21 02 2022
Historique:
received:
28
07
2021
revised:
27
08
2021
accepted:
30
08
2021
pubmed:
25
9
2021
medline:
28
4
2022
entrez:
24
9
2021
Statut:
ppublish
Résumé
Individuals with Phelan-McDermid syndrome (PMS) present with a wide range of developmental, medical, cognitive and behavioral abnormalities. Previous literature has begun to elucidate genotype-phenotype associations that may contribute to the wide spectrum of features. Here, we report results of genotype-phenotype associations in a cohort of 170 individuals with PMS. Genotypes were defined as Class I deletions (including SHANK3 only or SHANK3 with ARSA and/or ACR and RABL2B), Class II deletions (all other deletions) or sequence variants. Phenotype data were derived prospectively from direct evaluation, caregiver interview and questionnaires, and medical history. Analyses revealed individuals with Class I deletions or sequence variants had fewer delayed developmental milestones and higher cognitive ability compared to those with Class II deletions but had more skill regressions. Individuals with Class II deletions were more likely to have a variety of medical features, including renal abnormalities, spine abnormalities, and ataxic gait. Those with Class I deletions or sequence variants were more likely to have psychiatric diagnoses including bipolar disorder, depression, and schizophrenia. Autism spectrum disorder diagnoses did not differ between groups. This study represents the largest and most rigorous genotype-phenotype analysis in PMS to date and provides important information for considering clinical functioning, trajectories and comorbidities as a function of specific genetic alteration.
Identifiants
pubmed: 34559195
pii: 6374812
doi: 10.1093/hmg/ddab280
pmc: PMC8863417
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
625-637Subventions
Organisme : NICHD NIH HHS
ID : P50 HD105351
Pays : United States
Organisme : NINDS NIH HHS
ID : U54 NS092090
Pays : United States
Organisme : NINDS NIH HHS
ID : K01 NS126736
Pays : United States
Organisme : Intramural Research Program of the NIMH
ID : 1ZICMH002961
Organisme : NINDS NIH HHS
ID : R01 NS105845
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH113948
Pays : United States
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Références
Hum Genet. 2014 Jul;133(7):847-59
pubmed: 24481935
J Neurodev Disord. 2019 Jul 18;11(1):13
pubmed: 31319798
Autism Res. 2020 Aug;13(8):1383-1396
pubmed: 32406614
Mol Syndromol. 2012 Jun;3(1):14-20
pubmed: 22855650
Am J Occup Ther. 2007 Mar-Apr;61(2):190-200
pubmed: 17436841
J Child Lang. 2007 Aug;34(3):623-54
pubmed: 17822142
Mol Autism. 2013 Jun 11;4(1):17
pubmed: 23758743
Am J Med Genet A. 2018 Dec;176(12):2668-2676
pubmed: 30537371
Am J Med Genet A. 2013 Jan;161A(1):158-61
pubmed: 23166010
Am J Med Genet A. 2014 Mar;164A(3):806-9
pubmed: 24375995
Am J Med Genet A. 2014 Jul;164A(7):1666-76
pubmed: 24700646
Mol Autism. 2018 Apr 27;9:31
pubmed: 29719671
Am J Med Genet A. 2018 Dec;176(12):2791-2797
pubmed: 30216695
Am J Med Genet A. 2019 Sep;179(9):1718-1724
pubmed: 31215153
Am J Hum Genet. 2001 Aug;69(2):261-8
pubmed: 11431708
PLoS Genet. 2014 Sep 04;10(9):e1004580
pubmed: 25188300
Clin Genet. 2019 Nov;96(5):478-482
pubmed: 31403174
Eur J Med Genet. 2012 Nov;55(11):625-9
pubmed: 22922660
Orphanet J Rare Dis. 2015 Aug 27;10:105
pubmed: 26306707
Am J Med Genet A. 2005 Aug 30;137(2):139-47
pubmed: 16059935
Am J Med Genet A. 2021 Jul;185(7):2211-2233
pubmed: 33949759
Orphanet J Rare Dis. 2020 Nov 30;15(1):335
pubmed: 33256793
Eur J Med Genet. 2020 Mar;63(3):103751
pubmed: 31465867
J Med Genet. 2003 Sep;40(9):690-6
pubmed: 12960216
Genet Med. 2014 Apr;16(4):318-28
pubmed: 24136618
J Autism Dev Disord. 2007 May;37(5):855-66
pubmed: 17048092
Am J Med Genet A. 2018 Feb;176(2):391-398
pubmed: 29193617
J Neurodev Disord. 2014;6(1):39
pubmed: 25784960
J Autism Dev Disord. 1994 Oct;24(5):659-85
pubmed: 7814313
Mol Autism. 2019 Dec 24;10:50
pubmed: 31879555
NPJ Genom Med. 2017 Oct 23;2:32
pubmed: 29263841
J Med Genet. 2006 Oct;43(10):822-8
pubmed: 16284256
Am J Med Genet A. 2010 Mar;152A(3):573-81
pubmed: 20186804
Genet Med. 2019 Sep;21(9):2036-2042
pubmed: 30739909
BMC Med Genomics. 2020 Oct 6;13(1):146
pubmed: 33023580
Eur J Hum Genet. 2008 Nov;16(11):1301-10
pubmed: 18523453
J Neurodev Disord. 2020 Feb 12;12(1):7
pubmed: 32050889
Nat Genet. 2007 Jan;39(1):25-7
pubmed: 17173049
J Med Genet. 2011 Nov;48(11):761-6
pubmed: 21984749
J Med Genet. 2003 Aug;40(8):575-84
pubmed: 12920066
Front Psychiatry. 2019 Jul 30;10:526
pubmed: 31417436
Mol Syndromol. 2020 Jan;10(6):294-305
pubmed: 32021603
Cell. 2020 Feb 6;180(3):568-584.e23
pubmed: 31981491
Mol Autism. 2013 Jun 11;4(1):18
pubmed: 23758760